These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6096157)

  • 1. Physical dependence produced by chronic intracerebroventricular infusion of [D-Arg]kyotorphin or thiorphan to rats.
    Bean AJ; Vaught JL
    Eur J Pharmacol; 1984 Oct; 105(3-4):333-7. PubMed ID: 6096157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
    Haffmans J; Dzoljic MR
    Gen Pharmacol; 1987; 18(1):103-5. PubMed ID: 3549428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thiorphan on the antinociceptive actions of intrathecal [D-Ala2,Met5] enkephalin.
    Yaksh TL; Harty GJ
    Eur J Pharmacol; 1982 Apr; 79(3-4):293-300. PubMed ID: 7047177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of [D-ala2]enkephalinamide analgesia in rats by thiorphan.
    Chipkin RE; Latranyi MZ; Iorio LC; Barnett A
    Eur J Pharmacol; 1982 Sep; 83(3-4):283-8. PubMed ID: 6756941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiorphan potentiation of stress-induced analgesia in the mouse.
    Greenberg R; O'Keefe EH
    Life Sci; 1982 Sep 20-27; 31(12-13):1185-8. PubMed ID: 6755120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats.
    Kayser V; Guilbaud G
    Brain Res; 1983 May; 267(1):131-8. PubMed ID: 6574799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity.
    Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S
    J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone.
    Chipkin RE; Latranyi MB; Iorio LC
    Life Sci; 1982 Sep 20-27; 31(12-13):1189-92. PubMed ID: 6958954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
    Dzoljic MR
    NIDA Res Monogr; 1986; 75():575-8. PubMed ID: 3123978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent rats.
    Haffmans J; Walsum MV; van Amsterdam JC; Dzoljic MR
    Neuroscience; 1987 Jul; 22(1):233-6. PubMed ID: 2888045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous opiate reward induced by an enkephalinase inhibitor, thiorphan, injected into the ventral midbrain.
    Glimcher PW; Giovino AA; Margolin DH; Hoebel BG
    Behav Neurosci; 1984 Apr; 98(2):262-8. PubMed ID: 6586195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.
    Roques BP; Fournié-Zaluski MC; Soroca E; Lecomte JM; Malfroy B; Llorens C; Schwartz JC
    Nature; 1980 Nov; 288(5788):286-8. PubMed ID: 7001254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep.
    Rivière PJ; Buéno L
    Life Sci; 1987 Jul; 41(3):333-9. PubMed ID: 3298911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan.
    Livingston SJ; Sewell RD; Rooney KF; Smith HJ
    Psychopharmacology (Berl); 1988; 94(4):540-4. PubMed ID: 3131801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive effects of morphine and of an enkephalinase inhibitor on responses of ventro-basal thalamic neurones to noxious stimuli.
    Guilbaud G; Kayser V; Benoist JM; Gautron M
    Life Sci; 1983; 33 Suppl 1():545-7. PubMed ID: 6363853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin.
    Hiramatsu M; Nabeshima T; Fukaya H; Furukawa H; Kameyama T
    Eur J Pharmacol; 1986 Jan; 120(1):69-74. PubMed ID: 3456306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
    Marçais-Collado H; Uchida G; Costentin J; Schwartz JC; Lecomte JM
    Eur J Pharmacol; 1987 Dec; 144(2):125-32. PubMed ID: 3481337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid activity of enkephalin analogues containing the kyotorphin-related structure in the N-terminus.
    Amano H; Morimoto Y; Kaneko S; Takagi H
    Neuropharmacology; 1984 Apr; 23(4):395-400. PubMed ID: 6328351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enkephalinase 'A' inhibition by thiorphan: central and peripheral cardiovascular effects.
    Baum T; Becker FT; Sybertz EJ; Sabin C; Desiderio DM
    Eur J Pharmacol; 1983 Oct; 94(1-2):85-91. PubMed ID: 6360696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the hypoglycemic effect of insulin by thiorphan, an enkephalinase inhibitor.
    Chipkin RE; Kreutner W; Billard W
    Eur J Pharmacol; 1984 Jun; 102(1):151-4. PubMed ID: 6383841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.